Skip to main content
. 2022 Dec 11;11(24):4009. doi: 10.3390/cells11244009

Figure 2.

Figure 2

Ciliated cell markers CAPS and TUBB4 (mIF) in (A) benign serous cystadenoma, (B) serous borderline tumor, (C) serous low-grade carcinoma, (D) HGSOC, (E) high-grade endometrioid carcinoma, and (F) high-grade clear cell carcinoma. Images (left) are shown at higher magnification (right).